Literature DB >> 15522749

Binding of C3 fragments on top of adsorbed plasma proteins during complement activation on a model biomaterial surface.

Jonas Andersson1, Kristina Nilsson Ekdahl, John D Lambris, Bo Nilsson.   

Abstract

In the present study we investigate whether complement activation in blood in contact with a model biomaterial surface (polystyrene) occurs directly on the material surface or on top of an adsorbed plasma protein layer. Quartz crystal microbalance-dissipation analysis (QCM-D) complemented with enzyme immunoassays and Western blotting were used. QCM-D showed that the surface was immediately covered with a plasma protein film of approximately 8 nm. Complement activation that started concomitantly with the adsorption of the protein film was triggered by a self-limiting classical pathway activation. After adsorption of the protein film, alternative pathway activation provided the bulk of the C3b deposition that added 25% more mass to the surface. The build up of alternative pathway convertase complexes using purified C3 and factors B and D on different protein films as monitored by QCM-D showed that only adsorbed albumin, IgG, but not fibrinogen, allowed C3b binding, convertase assembly and amplification. Western blotting of eluted proteins from the material surface demonstrated that the C3 fragments were covalently bound to other proteins. This is consistent with a model in which the activation is triggered by initiating convertases formed by means of the initially adsorbed proteins and the main C3b binding is mediated by the alternative pathway on top of the adsorbed protein film.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15522749     DOI: 10.1016/j.biomaterials.2004.05.011

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  48 in total

1.  DEHP Nanodroplets Leached From Polyvinyl Chloride IV Bags Promote Aggregation of IVIG and Activate Complement in Human Serum.

Authors:  Jared R Snell; Connor R Monticello; Cheng Her; Emma L Ross; Ashley A Frazer-Abel; John F Carpenter; Theodore W Randolph
Journal:  J Pharm Sci       Date:  2019-06-21       Impact factor: 3.534

2.  A stimulus-responsive contrast agent for ultrasound molecular imaging.

Authors:  Mark A Borden; Hua Zhang; Robert J Gillies; Paul A Dayton; Katherine W Ferrara
Journal:  Biomaterials       Date:  2007-10-30       Impact factor: 12.479

Review 3.  Compstatin: a complement inhibitor on its way to clinical application.

Authors:  Daniel Ricklin; John D Lambris
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

4.  Blood protein-polymer adsorption: implications for understanding complement-mediated hemoincompatibility.

Authors:  Anna E Engberg; Jenny P Rosengren-Holmberg; Hui Chen; Bo Nilsson; John D Lambris; Ian A Nicholls; Kristina N Ekdahl
Journal:  J Biomed Mater Res A       Date:  2011-02-11       Impact factor: 4.396

5.  Nanomedicine for gene therapy.

Authors:  Susan Muthe Alex; Chandra P Sharma
Journal:  Drug Deliv Transl Res       Date:  2013-10       Impact factor: 4.617

6.  Inhibition of complement activation on a model biomaterial surface by streptococcal M protein-derived peptides.

Authors:  Anna E Engberg; Kerstin Sandholm; Fredrik Bexborn; Jenny Persson; Bo Nilsson; Gunnar Lindahl; Kristina N Ekdahl
Journal:  Biomaterials       Date:  2009-01-25       Impact factor: 12.479

Review 7.  Chronic inflammation in biomaterial-induced periprosthetic osteolysis: NF-κB as a therapeutic target.

Authors:  Tzu-hua Lin; Yasunobu Tamaki; Jukka Pajarinen; Heather A Waters; Deanna K Woo; Zhenyu Yao; Stuart B Goodman
Journal:  Acta Biomater       Date:  2013-10-01       Impact factor: 8.947

8.  Mediation of a non-proteolytic activation of complement component C3 by phospholipid vesicles.

Authors:  Yvonne Klapper; Osama A Hamad; Yuji Teramura; Gero Leneweit; G Ulrich Nienhaus; Daniel Ricklin; John D Lambris; Kristina N Ekdahl; Bo Nilsson
Journal:  Biomaterials       Date:  2014-01-23       Impact factor: 12.479

Review 9.  Can cells and biomaterials in therapeutic medicine be shielded from innate immune recognition?

Authors:  Bo Nilsson; Olle Korsgren; John D Lambris; Kristina Nilsson Ekdahl
Journal:  Trends Immunol       Date:  2010-01       Impact factor: 16.687

10.  Investigation of interaction of vaccinia virus complement control protein and curcumin with complement components c3 and c3b using quartz crystal microbalance with dissipation monitoring technology.

Authors:  Amod P Kulkarni; Philippa J Randall; Krishna Murthy; Lauriston A Kellaway; Girish J Kotwal
Journal:  Open Biochem J       Date:  2010-01-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.